Results 101 to 110 of about 14,085 (196)

Evaluation of a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-induced mouse model in a comparative experimental study of portal hypertension. [PDF]

World J Gastroenterol
Zhao JB, Wu ZH, Lin JY, Luo GQ, Zhang CH, Wu GB, Fan Q, Qi XL, Huo HZ, Yu JW, Li HJ, Zheng L, Luo M.   +12 more
europepmc   +1 more source

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. [PDF]

Nat Med
Bolsewig K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, Vermunt L, Lleó A, Alcolea D, Sieben A, Engelborghs S, Simonsen AH, Hasselbalch SG, Bech S, Morrema THJ, Hoozemans JJM, Bol JGJM, van Alphen J, Gaetani L, Chiasserini D, Paolini Paoletti F, Parnetti L, Kang S, Lee YG, Jeon S, Lee A, Jeon S, Ye BS, Del Campo Milán M, van der Flier WM, van de Berg WDJ, Lemstra AW, Willemse EAJ, Teunissen CE.   +31 more
europepmc   +1 more source

Activation of aryl hydrocarbon receptor alleviates cholestatic liver injury by inhibiting inflammation. [PDF]

Cell Commun Signal
Han Q, Wang L, Yan X, Zhang N, Zhang W, Li H, Chen W, You H, Yang A.   +8 more
europepmc   +1 more source

Disulfiram metabolite Cu(DDC)₂ enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance. [PDF]

EBioMedicine
Brookes K, Fear JS, Thornton CEM, Zha L, Kim J, Small B, Wongsanit S, Nieto HR, Adcock H, Jones A, Pham TT, Bottegoni G, Cox LR, Kannappan V, Wang W, Gorvin CM, Stover DG, Spitzweg C, Jhiang S, Ringel MD, Campbell MJ, Sunassee K, Blower PJ, Boelaert K, Smith VE, Read ML, McCabe CJ.   +26 more
europepmc   +1 more source

Evaluation of the mechanism underlying melatonin action in cholestatic liver disease treatment via network pharmacology, molecular docking, and in vivo experiments. [PDF]

PLoS One
Li T, ZhenYu J, Jing W.
europepmc   +1 more source

Dietary Lauric Acid Suppresses Inflammation, Cholestasis, Hepatocyte Injury, and Senescence in 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced Inflammatory Cholangiopathy. [PDF]

Cell Mol Gastroenterol Hepatol
Ghosh S, Devereaux MW, Anderson AL, Anderson CC, D'Alessandro A, Orlicky DJ, Sokol RJ.   +6 more
europepmc   +1 more source

DDC

netbib, 2003
openaire   +1 more source

DDC wt Allele [PDF]

, 2020
openaire   +1 more source

Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation

International Journal of Nanomedicine
Wojciech G Lesniak,1 Srikanth Boinapally,1 Gabriela Lofland,1 Zirui Jiang,1 Catherine A Foss,1 Babak Behman Azad,1 Anna Jablonska,1,2 Mauro A Garcia,1 Maria Brzezinski,1 Martin G Pomper1,3 1Russell H.
Lesniak WG, Boinapally S, Lofland G, Jiang Z, Foss CA, Behman Azad B, Jablonska A, Garcia MA, Brzezinski M, Pomper MG   +9 more
doaj  

The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion. [PDF]

Commun Biol
Liu M, Su Y, Hu Y, Shen M, Bao S, Gong Y, Ji Y, Wang L, Zhang Y, Wang X, Yang H, Chang Y, Zhou L.   +12 more
europepmc   +1 more source